Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Parkinson's DiseaseGaucher's Disease
Interventions
DRUG

N-acetylcysteine

Single, intravenous administration of N-acetylcysteine

Trial Locations (1)

55455

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

Rare Diseases Clinical Research Network

NETWORK

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Minnesota

OTHER

NCT01427517 - Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease | Biotech Hunter | Biotech Hunter